Overview: Thyroid-Stimulating Immunoglobulin TestIntroduction: The Thyroid-Stimulating Immunoglobulin Test detects TSI to diagnose hyperthyroidism, causing heart palpitations or anxiety. Following 2023 ATA guidelines, it uses immunoassays for high specificity, supporting hormonal screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in immunology for patients with suspected hyperthyroidism.
Other Names: TSI Assay, Thyroid-Stimulating Antibody Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: TSI testing began in the 1980s with hyperthyroidism research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects TSI to diagnose hyperthyroidism, guides treatment, and evaluates patients with heart palpitations or anxiety.
Test Parameters: 1. TSI Level
Pretest Condition: No fasting required. Collect serum or saliva. Report history of heart palpitations, anxiety, or hyperthyroid symptoms.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document heart palpitations, anxiety, or history of hyperthyroidism. Include current medications, especially antithyroid drugs.
Consent: Written consent required, detailing the tests purpose, hyperthyroidism implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) or bioassay to detect TSI levels. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for hyperthyroidism diagnosis.
Factors Affecting Result Accuracy: Sample hemolysis or improper storage can affect results. Medications like methimazole may alter TSI levels.
Clinical Significance: Positive TSI confirms hyperthyroidism, guiding antithyroid therapy or surgery. Negative results may require TSH receptor antibody or thyroid scan.
Specialist Consultation: Consult an endocrinologist for result interpretation and treatment planning.
Additional Supporting Tests: TSH receptor antibodies, thyroid scan, or free T4 to confirm hyperthyroidism diagnosis.
Test Limitations: Non-specific for other hyperthyroid conditions; clinical correlation is needed. Sample quality affects sensitivity.
References: ATA Thyroid Guidelines, 2023; Journal of Clinical Endocrinology, Ross DS, 2022.
